Is Calyxt, Inc. (CLXT) a Buy, Sell, or Hold?
NASDAQ : CLXT
Calyxt, Inc.
$6.3 USD
$0.33 (5.53%)
- Volume
- 254.09K
- Average Volume
- 22.52K
- Market Capitalization
- $31.33M
- P/E Ratio
- -3.20
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $38.85
- Year Low
- $6.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.37
Company Overview
NASDAQ
Michael Allen Carr
Packaged Foods
Consumer Defensive
CLXT
48
US
USD
Liquidity Metrics
0.90
2.37
2.37
2.17
0.00
Sales & Valuation
$3.64M
7.31
115.78
-0.62
-0.08
Profitability
-$2.78
-$127.08M
-2384.11%
-2426.43%
-227.28%
-31.52%
P/E Metrics
-3.20
-0.01
-0.01
Analyst Price Target & Rating
0/5
11 Analysts
%
Financial Health Scores
-3.99
3/9
$19.12M
$324.2M
$288.72M
-$33.14M
Key Metrics (TTM)
$33.12M
7.73
-1.20
2.37
-227.28%
-21.73%
-2.49%
-161.65%
145 days
Company Executives
| Name | Title |
|---|---|
| Daniel F. Voytas | Founder, Chief Science Officer & Chair of Scientific Advisory Board |
| William F. Koschak | Chief Financial Officer |
| Michael Allen Carr | Pres, Chief Executive Officer & Director |
| Debra H. Frimerman | Gen. Counsel & Corporation Sec. |
| Trina Lundblad | Director of Communications |
| Travis J. Frey | Chief Technology Officer |
| Stephen Bravo | Chief Medical Officer |
| Suellen Boot | Bus. Devel. Director |
| Gerry Nuovo | Senior Vice President of Bus. Devel. |
Poll Results
No votes yet today — be the first to share your view!
About Calyxt, Inc. (NASDAQ:CLXT) Stock
Calyxt, Inc. is a synthetic biology firm that engineers plant-based solutions, primarily serving the agricultural industry in the United States. The company innovates in areas such as developing easily digestible alfalfa, cultivating hemp, and producing wheat varieties with elevated fiber content. They hold an exclusive commercialization pact with S&W Seed Company to license their superior alfalfa seed across both U.S. and international markets. Established in 2010 and headquartered in Roseville, Minnesota, the entity operated as Cellectis Plant Sciences, Inc. before adopting the name Calyxt, Inc. in May 2015. Calyxt, Inc. functions as a subsidiary of Cellectis S.A. ...
Frequently Asked Questions
-
What is the current Calyxt, Inc. (CLXT) stock price?
-
Calyxt, Inc.(NASDAQ:CLXT) stock price is $6.3 in the last trading session. During the trading session, CLXT stock reached the peak price of $38.85 while $6.01 was the lowest point it dropped to. The percentage change in CLXT stock occurred in the recent session was 5.53% while the dollar amount for the price change in CLXT stock was $0.33.
-
CLXT's industry and sector of operation?
-
The NASDAQ listed CLXT is part of Packaged Foods industry that operates in the broader Consumer Defensive sector.
-
Who are the executives of CLXT?
-
Daniel F. Voytas | Founder, Chief Science Officer & Chair of Scientific Advisory Board
William F. Koschak | Chief Financial Officer
Michael Allen Carr | Pres, Chief Executive Officer & Director
Debra H. Frimerman | Gen. Counsel & Corporation Sec.
Trina Lundblad | Director of Communications -
How many employees does CLXT have?
-
Number of CLXT employees currently stands at 48. CLXT operates from 2800 Mount Ridge Road, Roseville, MN 55113-1127, US.
-
Link for CLXT official website?
-
Official Website of CLXT is: https://calyxt.com
-
How do I contact CLXT?
-
CLXT could be contacted at phone #651 683 2807 and can also be accessed through its website. CLXT operates from 2800 Mount Ridge Road, Roseville, MN 55113-1127, US.
-
How many shares of CLXT are traded daily?
-
The average number of CLXT shares traded daily for last 3 months was 22.52K.
-
What is the market cap of CLXT currently?
-
The market value of CLXT currently stands at $31.33M with its latest stock price at $6.3